EMD Serono: Philippe M Lopes-Fernandes. Closure of Geneva site creates opportunities for new business successes




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: EMD Serono: Philippe M Lopes-Fernandes. Closure of Geneva site creates opportunities for new business successes
Released on: April 30, 2013. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Philippe M Lopes-Fernandes, Senior VP, Head of Global Licensing, Business Development and Alliance Management at EMD Serono.
  • Summary
  • Transcript
  • Participants
  • Company
In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Philippe M Lopes-Fernandes, Senior VP, Head of Global Licensing, Business Development and Alliance Management at EMD Serono.
In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Philippe M Lopes-Fernandes, Senior VP, Head of Global Licensing, Business Development and Alliance Management at EMD Serono.
Philippe M Lopes-Fernandes
EMD Serono
EMD Serono
EMD Serono, Inc. is a leader in the U.S. biopharmaceutical industry. We have more than 1,000 employees throughout the United States with fully integrated commercial, clinical, and research operations near Boston and headquarters in Rockland, Massachusetts. EMD Serono has more than 30 trials in our global clinical pipeline, focused on developing innovative therapies for cancer and neurodegenerative diseases such as multiple sclerosis and Parkinson's disease.